Product Type
Condition
Binding
Collectible Attributes
Seller Location
Seller Rating
Published by CRC Press, 2017
ISBN 10: 1138775509ISBN 13: 9781138775503
Seller: Books From California, Simi Valley, CA, U.S.A.
Book
paperback. Condition: Very Good.
Published by CRC Press 2017-07-27, Boca Raton, 2017
ISBN 10: 1138775509ISBN 13: 9781138775503
Seller: Blackwell's, London, United Kingdom
Book
paperback. Condition: New. Language: ENG.
Published by CRC Pr I Llc, 2017
ISBN 10: 1138775509ISBN 13: 9781138775503
Seller: Revaluation Books, Exeter, United Kingdom
Book
Paperback. Condition: Brand New. 646 pages. 11.00x8.50x1.30 inches. In Stock.
Published by Taylor & Francis Ltd, 2017
ISBN 10: 1138775509ISBN 13: 9781138775503
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering.
Published by CRC Press, 2017
ISBN 10: 1138775509ISBN 13: 9781138775503
Seller: GoldBooks, Denver, CO, U.S.A.
Book
Paperback. Condition: new. New Copy. Customer Service Guaranteed.
Published by CRC Press 2015-12-10, 2015
ISBN 10: 1498743471ISBN 13: 9781498743471
Seller: Chiron Media, Wallingford, United Kingdom
Book
Hardcover. Condition: New.
Published by CRC Press, 2015
ISBN 10: 1498743471ISBN 13: 9781498743471
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book Print on Demand
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Even very established companies have made mistakes when developing biosimilar products. For example, not appreciating future threats to intellectual property caused a biosimilar product development plan to fail after millions have been spent. Additional pitfalls include not anticipating the next line of improved products, better formulations, delivery systems and the possibility that the dosing and indications can themselves be patented. This two-volume set examines how to choose the right product to develop and how to meander around the legal fireworks and secure a viable commercial presence.
Published by CRC Pr I Llc, 2015
ISBN 10: 1498743471ISBN 13: 9781498743471
Seller: Revaluation Books, Exeter, United Kingdom
Book
Hardcover. Condition: Brand New. 1st edition. 599 pages. 11.00x8.50x1.50 inches. In Stock.
Published by CRC Press, 2015
ISBN 10: 1498743471ISBN 13: 9781498743471
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Sarfaraz K. Niazi, PhD, is the founding executive chairman of Therapeutic Proteins International LLC, a world-class pure-play developer and manufacturer of biosimilar and interchangeable recombinant biologics, headquartered in Chicago. D.